Oryzon Genomics (MEX:ORYN) Buyback Yield %: 0.00 (As of Jun. 25, 2026)


MEX:ORYN Oryzon Genomics SA MEX:ORYN
31 GF Score
Price MXN48.59
View Full Analysis

What is Oryzon Genomics Buyback Yield %?

Oryzon Genomics MEX:ORYN 31 Buyback Yield % is 0.00 as of Jun. 25, 2026. GuruFocus rates MEX:ORYN with a GF Score™ of 31/100. Among 745 Biotechnology companies, Oryzon Genomics ranks worse than 134228.05% on this metric.

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Oryzon Genomics's current buyback yield was 0.00%.

Oryzon Genomics Buyback Yield % Historical Data

* Premium members only.

The historical data trend for Oryzon Genomics's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Oryzon Genomics Buyback Yield % Chart

Oryzon Genomics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Buyback Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.06 -16.09

Oryzon Genomics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Buyback Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 -11.92 0.00

MEX:ORYN vs VRTX, REGN, ALNY: Buyback Yield % Comparison

For the Biotechnology subindustry, Oryzon Genomics's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Oryzon Genomics Buyback Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oryzon Genomics's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Oryzon Genomics's Buyback Yield % falls into.


MEX:ORYN
31GF Score
Oryzon Genomics SA MEX:ORYN
Buyback Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Oryzon Genomics Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Oryzon Genomics's Buyback Yield for the fiscal year that ended in Dec. 2025 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (0 + 606.036) / 3766.35667
=-16.09%

Oryzon Genomics's annualized Buyback Yield for the quarter that ended in Mar. 2026 is calculated as

Buyback Yield=Net Issuance of Stock(TTM) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) (TTM)** / Market Cap
=- (0 + 0) / 3766.35667
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Frequently Asked Questions Learn more about Buyback Yield % →
What does a Buyback Yield % of 0.00 mean?
Oryzon Genomics (MEX:ORYN) has a Buyback Yield % of 0.00 as of Jun. 25, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Oryzon Genomics and its competitors. According to the industry distribution chart, Oryzon Genomics ranks #999999 out of 745 companies in the Biotechnology industry.
Is Oryzon Genomics' Buyback Yield % too high?
Oryzon Genomics' current Buyback Yield % is 0.00. Based on the distribution chart, Oryzon Genomics ranks #999999 out of 745 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Oryzon Genomics has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Oryzon Genomics' Buyback Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Oryzon Genomics ranks #999999 out of 745 companies for Buyback Yield %. This places Oryzon Genomics in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Biotechnology company?
A good Buyback Yield % depends on the Biotechnology industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Oryzon Genomics and its competitors. Oryzon Genomics's current Buyback Yield % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Oryzon Genomics stock overvalued right now?
Oryzon Genomics (MEX:ORYN) has a current Buyback Yield % of 0.00. The current Buyback Yield % is 0.00. Oryzon Genomics' overall GF Score™ is 31/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Oryzon Genomics (MEX:ORYN), the current Buyback Yield % is 0.00 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Oryzon Genomics Business Description

Address Sant Ferran 74, Cornellà de Llobregat, Barcelona, ESP, 08940
Oryzon Genomics SA is a clinical stage biopharmaceutical company and engaged in the development of epigenetics-based therapeutics. It is engaged in the field of epigenetic medicine and in the development of therapeutic, biological solutions for cancer and neurodegenerative diseases.
31GF Score

Get the complete analysis for MEX:ORYN

Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN48.59
Price